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Abstract
Background: Due to the increased accuracy of Copy Number Variable region (CNV) break point mapping, it is now possible
to say with a reasonable degree of confidence whether a gene (i) falls entirely within a CNV; (ii) overlaps the CNV or (iii)
actually contains the CNV. We classify these as type I, II and III CNV genes respectively.
Principal Findings: Here we show that although type I genes vary in copy number along with the CNV, most of these type I
genes have the same expression levels as wild type copy numbers of the gene. These genes must, therefore, be under
homeostatic dosage compensation control. Looking into possible mechanisms for the regulation of gene expression we
found that type I genes have a significant paucity of genes regulated by miRNAs and are not significantly enriched for
monoallelically expressed genes. Type III genes, on the other hand, have a significant excess of genes regulated by miRNAs
and are enriched for genes that are monoallelically expressed.
Significance: Many diseases and genomic disorders are associated with CNVs so a better understanding of the different
ways genes are associated with normal CNVs will help focus on candidate genes in genome wide association studies.
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Introduction
Detectable copy number variable (CNV) regions vary greatly in
size, from macroscopic mutations, visible as gain or loss of
heterochromatic bands, down to regions of a just a few kilobases.
Recent developments in CNV detection have brought the field
into even closer focus with CNVs as small as 500 nucleotides being
detected [1]. These CNVs may be so small that they are entirely
contained within a gene. Larger CNVs may cover whole genes
and can be up to several megabases long. CNVs have been
associated with many genomic disorders such as Charcot–Marie–
Tooth disease, as well as diseases such as hypertension and
schizophrenia and may also be associated with susceptibilities to
certain cancers. [2].
It has been presumed that the expression of CNV genes would
correlate with copy number, so that for example, a gene that has
one allele duplicated (copy number of 3) would have 1.5 times the
level of expression of the wild type copy number of 2. In other
words an expression ratio of 1.5 (3:2).
Stranger et al. [3] showed that SNPs are responsible for 83.6%
of the detectable variation in expression among individuals
compared with only 17.7% that is due to CNVs despite the fact
that CNVs cover a greater proportion of an individuals genome
than is covered by SNPs. Some of this variation in expression is
due to CNVs that lie upstream of a gene disrupting the regulatory
regions. Stranger et al. [3] agreed with recent work in this lab by
Schuster-Bo ¨ckler et al. [4] that there is a significant difference in
the expression ratios between duplicated and deleted genes, and
that this difference is much smaller than expected. A similar result
has also been found in mouse [5]. However, there were a number
of caveats that may have led to these results, including the fact that
the precise CNV breakpoints were unknown so that it was possible
that genes were being included that were not truly within the
CNV, and vice versa, which would bias the mean expression levels.
Not knowing the precise breakpoints might also lead to the
inclusion of genes which partially overlap the CNV. In this case
only a part of the gene is in multiple copy, so that a supposed copy
number of 3 may be only one functional allele and two disrupted
alleles. This would also bias average expression ratios for amplified
genes. However, recent work by Conrad et al. [1] has produced a
new dataset of CNVs with breakpoints that are claimed to be
accurate to within 60 nucleotides. This improvement in the
accuracy of break point prediction allows us to say with a much
greater degree of certainty that a gene is fully between the
breakpoints of a CNV or not.
This work uses the Conrad et al. [1] CNV coordinates for those
individuals that we have expression data for from Stranger et al.
[4]. Only Ensembl protein coding genes where the coding region
or UTR of the gene overlaps with a CNV are included. The
accuracy of the predicted CNV breakpoint coordinates from
Conrad et al. [1] means that we can be reasonably confident that
only the genes that fall entirely within CNVs, will be included
when testing the correlation of expression with copy number. The
characteristics and potential mechanisms for the regulation of
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other categories of CNV associated genes (described below).
Results
Classification of CNV Associated Genes
The genes that vary in copy number and that are contained
entirely within the CNV are the most obvious class of genes to
consider when talking about CNV associated genes. We classified
these genes as type I CNV genes (blue gene in figure 1). However,
there are two other possible structural relationships between gene
and CNV. The first of these is where one CNV break point is
found within a gene so that the gene partially overlaps the CNV.
We classified these genes as type II (green genes in figure 1). These
type II genes are often disrupted and may even form fusion genes.
For example, the two type II genes in figure 1 might form a fusion
gene if the CNV were deleted or duplicated in situ. Fusion genes,
although rare, are thought to occur most frequently between
paralogues. Type III genes are those that contain the CNV within
the gene. These genes may also be disrupted depending on
whether the CNV excises exons that are in phase or not. Overall,
type II and III genes will have the wild type copy number and are
therefore expected to have the wild type expression unless the gene
(or it’s regulatory regions) are disrupted by the CNV.
CNV Gene Characteristics
In order to better understand the biology of these three types of
CNV genes we looked at a few basic characteristics, such as,
mutation rates, possible selective pressures and the type of genes
involved. There are 420 type I genes, 378 type II and 1172 type III
genes (table 1). Type one genes are shorter on average (19,291
nucleotides (nt)) than type II (58,362 nt) which are it turn much
shorter than type III genes (236,909 nt). Which is not surprising
when we think that type III genes contain CNVs whilst type I
genes are contained within CNVs. However, the length of overlap
between the CNV and the gene shows the opposite trend with type
I genes overlapping on average by 19,291 nt, type II by 7,990 nt
and type III by 4,731 nt.
Type I genes appear to be evolving rapidly as measured by the
median dN plus dS values. (See table 2.) The mean value is a little
lower than that for type II genes but in this case just a small
number of very rapidly evolving genes (or which were perhaps
mislabelled as orthologues) have skewed the mean values. Some
type I genes even appear to be under positive selection (mean dN/
dS greater than one). Most of the type I genes in CNVs appear to
show increased variation and mutation rates compared with the
genome as a whole. Many, such as the MHC (HLA) genes are
under density dependent balancing selection [6] due to their
important role in the immune response’s ‘‘arms race’’ against
constantly varying pathogens. On the whole type I genes tend to
be involved in the immune response, as may be seen from table 3,
with three of the top four categories of genes being involved in
various aspects of both the adaptive and the innate immune
systems.
The type III genes tend to be involved in cell cell signalling and
are enriched for extracellular domains such as SH3 (table 3).
These genes appear to be mutating more slowly than genes in the
rest of the genome as measured by either the mean or the median
dN plus dS. The very low dN/dS values would appear to indicate
that strong negative selection is acting on type III genes (table 2).
The properties of type II genes appear to lie somewhere
between type I and III and share some gene functions type I
(keratins) and type III (cell adhesion) genes (table 3). The mutation
rate and selective pressures also occupy the middle ground and as
such give the appearance of not being significantly different from
non-CNV genes (table 2).
Gene Expression
The expression ratio analysis of Schuster-Bo ¨ckler et al. [4] was
repeated with the Conrad et al. [1] CNV data set using only the
type I genes. As figure 2 shows, despite the increased accuracy of
these CNVs most genes, whether duplicated or deleted, have
expression levels very similar to the wild type expression level
(expression ratio of one) with a difference in means of just 0.026
between them. This may be seen more clearly in figure 3, which
shows the expression ratios plotted for each type I gene. The
graphs for both the duplicated and deleted genes show that most
genes have an expression ratio of one (the straight horizontal
stretch of the graph) with only a few genes at either end of the
graph that have expression ratios that differ greatly from one.
Similar shaped graphs are also produced for type II and III genes
(Supplemental figure S1) which would imply that the copy number
of the gene does not affect the expression of type I genes as only
parts of the type II and III genes vary in copy number not the
whole gene. This apparent lack of correlation of gene dosage on
expression levels suggests that the type I genes must be under tight
homeostatic regulation that somehow compensates for gene
dosage. Although, the whole of type II and III CNV genes do
not vary in copy number, their expression ratios do vary in a
similar way to type I genes so may also require dosage
compensation mechanisms to cover the affects of disrupted alleles
or missing regulatory regions.
Dosage Compensation. Gene expression regulation and
therefore, dosage compensation, is a complex process involving
many different stages before, during and after transcription.
Pretranscriptionally, the position of the chromosome within the
nucleus [7], the chromatin conformation, [8] histone and DNA
Figure 1. Schematic illustrating the three different categories of CNV genes. Type I genes vary in copy number whilst type II and III genes
have the wild type copy number. Type III genes contain the CNV region within the gene. The CNV may overlap an intron, exon, or UTR. Here the CNV
is shown overlapping an exon. Type II genes overlap with the CNV region. In the example shown here, the CNV break points lie within two different
genes. In this example fusion genes would be created by the CNV. It is more common though for just the 59 or 39 end of the gene to be lost or
duplicated.
doi:10.1371/journal.pone.0014814.g001
CNV Gene Classification
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or activators are bound can all affect whether a gene is transcribed
[9]. During transcription even the speed of RNA polymerase II
affects splicing which can alter the transcript produced and may
even lead to a nonsense transcript being produced [10]. In this
case post transcriptional regulation in the form of nonsense
mediated decay would destroy the transcript so no gene product is
produced [11]. Unfortunately, we still do not have the data to be
able to check which, if any, of these particular methods are
involved in dosage compensation. We do have the data to look at
miRNA regulation, imprinting and monoallelic expression as
mechanisms which may be involved in homeostatic regulation of
gene product levels.
Monoallelic Expression. Dosage compensation by imprinted
or monoallelically expressed genes has been well documented
although we do not fully understand the mechanisms involved.
Imprinted genes are thought to have one parental allele switched off
by antisense non-coding RNAs [12]. Monoallelic genes may have
either allele expressed irrespective of the parent of origin although
the mechanism that controls which allele is expressed is not
understood. If CNV genes are imprinted or monoallelically
expressed this may explain why there is so little correlation of
expression levels with copy number. The 160 imprinted genes [13]
and the 525 experimentally verified monoallelically expressed genes
from Gimelbrant et al. [14] were compared to the CNV genes.
Imprinted genes tend to be expressed in a parent of origin fashionin
specific tissues, such as the brain, or during development. Only
seven imprinted genes are found in the experimentally verified
monoallelically expressed data set. This is presumably due to fact
that only the lymphoblastoid cell lines were tested.
Table 4 shows that imprinted genes are neither enriched nor
underrepresented in all three gene types. However, type I genes
show a paucity of monoallelically expressed genes whilst type III
genes are significantly enriched for them. This result is interesting
as it completely contradicts our hypothesis that monoallelic
expression mechanisms might be a possible dosage compensation
mechanism for type I genes.
miRNA Regulation. It is thought that regulation of
expression by miRNAs represents a layer of homeostatic fine
tuning that mops up excess transcripts by pairing with a target site
in the 39UTR of the gene and either destabilising the mRNA or
marking it for decay (see Bartel [15] for review). There is also
evidence that miRNAs may be able to activate transcription [16].
Li et al. [17] suggest that duplicated genes (paralogues) may be
preferentially regulated by miRNAs, although, some current
estimates predict that actually most human genes may have their
expression regulated by miRNAs [18].
Regulation of expression by miRNAs seems to be a likely
mechanism to have evolved to regulate type I genes as miRNAs
recognise conserved ‘‘seed’’ sites in the 39UTR which are unlikely
to be disrupted in type I genes. Therefore, regulation of expression
by miRNAs may be part of the homeostatic mechanism that
underlies the cell’s ability to dosage compensate for variable
numbers of copies of a gene. Type II and III genes may be less
likely to be regulated by miRNAs as the 39UTRs may be disrupted
in these gene classes.
To test the hypothesis that CNV type I genes have their
expression regulated by miRNAs, an experimentally verified set of
miRNA target genes [19] were mapped to the Ensembl gene set.
Of the 384 genes mapped, only 5 were found to be type I genes,
which is not significantly different from the 8 expected by chance
(x
2=0.849, p=0.357). It was felt that this dataset, although
accurate as the genes were experimentally verified as being
regulated by miRNAs, was too small as it is thought that most
human genes may be regulated by miRNAs [18]. Two sets of
predicted miRNA targets were obtained from miRGen [20] who
have combined miRanda [21], PicTar [22] and TargetScanS [18]
prediction methods (See Methods for details).
Table 1. Mean and median values for length of genes, and CNV gene overlaps for the three types of CNV genes.
Number Mean (median) length Mean (median) overlap
Mean (median) Percent overlap wrt the
gene
Type I 420 19291 (8284) 19291 (8284) 100 (100)
Type II 378 58362 (25990) 7990 (2399) 27.962 (18.092)
TypeIII 1172 236909 (145109) 4731 (2195) 5.275 (1.804)
doi:10.1371/journal.pone.0014814.t001
Table 2. Mean and median values for dN/dS and dN+dS for the three types of CNV genes and non CNV genes.
Gene type
dN/dS
mean (median)
Kolmogorov-Smirnov Test
Probability (direction of
significance) dN + dS mean (median)
Kolmogorov-Smirnov Test
Probability (direction of
significance)
I 1.1598 (0.4364) 1.113610
210 q *** 0.03450 (0.0250) 2.168610
211 q ***
II 0.6118 (0.2941) 0.01801 q * 0.04161 (0.0226) 1.628610
28 q ***
III 0.3132 (0.2027) 0.001491 Q *** 0.02958 (0.0169) 0.04667 Q *
Non CNV 0.4522 (0.2308) NA 0.03435 (0.0172) NA
Probability values for the Kolmogorov-Smirnov test are given for the comparison of the CNV gene type and non CNV genes.
Significance is indicated by
***= p,0.005
**= p,0.01
*= p,0.05
Arrows show whether the CNV genes are evolving more rapidly than non CNV genes q or more slowly Q.
doi:10.1371/journal.pone.0014814.t002
CNV Gene Classification
PLoS ONE | www.plosone.org 3 May 2011 | Volume 6 | Issue 5 | e14814The first dataset analysed was a conservative ‘‘Intersection’’
dataset, where all three prediction methods must predict the same
miRNA target for that gene miRNA pairing to be included. The
second ‘‘Union’’ dataset counted all targets predicted by any of the
three methods. Table 5 shows the results for these analyses. The
Intersect set predicted that 15 of the type I genes would have their
expression regulated by miRNAs. A x
2 test showed that this is
significantly fewer than the 39.5 genes expected by chance
(x
2=14.47, p=0.00014). This paucity of miRNA regulated genes
in the type I CNV genes, was also found for the Union dataset
where 352 rather than 392.1 miRNA target genes were found
(x
2=54.93, p=1.25610
213). (A more liberal Intersection, dataset
that required any two of the three methods to predict a target for
the gene for that gene to be included, also showed a significant lack
of miRNA targeted genes in the type I genes. (57 genes rather than
the predicted 158.2 expected; x
2=105.25 p,2.2610
216).
This lack of type I CNV genes potentially regulated by miRNAs
was surprising but perhaps not so strange as the observation that
type III genes appear to have a significant enrichment for genes
predicted to be regulated by miRNAs. Type II genes again fall
between type I and III and have nearly the expected number of
genes regulated by miRNAs as predicted by both the Intersection
and Union datasets. Results for both datasets and the three gene
types are shown in table 5.
Even those type I genes that do have predicted miRNA targets
are regulated by significantly fewer miRNAs than genes in the rest
of the genome for the Union dataset (Kolmogorov-Smirnov test D
=0.2347, p=5.058610
211). The type I genes were found to have
significantly shorter 39UTRs than genes in the rest of the genome
with a mean of 914 nucleotides compared with 1266 for the
rest of the genome (Kolmogorov-Smirnov test D =0.195,
p=1.965610
207). As we know, a miRNA may have a number
of targets in the same UTR so that a gene might be regulated by
just one miRNA but have, for example, five targets sites for it in
the 39UTR while another gene may also have five targets but be
regulated by three different miRNAs. While there is a correlation
with number of targets and 39UTR length there is no correlation
between number of miRNAs regulating the gene and the 39UTR
length. There is a very significant positive correlation between the
numbers of targets found in the 39UTR (Pearson p-value
,2.2610
216) and the length of the 39UTR but not with the
number of miRNAs involved (p-value =0.2355). Therefore,
although the type I genes do tend to have shorter 39UTRs this
is unlikely to be the reason for the paucity in miRNAs regulating
the expression of these genes as there is no correlation with the
number of miRNAs and the 39UTR length.
Type III genes were found to have opposite characteristics to
the type I genes. They have an enrichment for genes with
predicted miRNA targets for both the Intersection and Union data
sets, as seen in table 5. They also have significantly more predicted
miRNAs per gene, as well as more target sites per gene and
significantly longer 39UTRs than the non-CNV genes. Type II
genes have approximately the expected numbers of miRNA
targets in both the Intersection and Union datasets. They also
have similar numbers of predicted miRNAs and predicted targets
as the non-CNV genes. Even the 39UTR lengths display a similar
distribution as non-CNV genes.
It should be noted that further subdividing the gene types by
allele type depending on whether the CNV was normally a
deletion, an amplification or could occur as both, had no affect. All
three allele types appear to give similar results (results not shown).
Discussion
The three categories of genes based on their physical association
to a CNV appear to also have coherent biological themes. The
results for the three categories were very different and often
surprising with some being the opposite of what we had initially
hypothesised. Here we will discuss the findings for each gene type
in turn.
Ohno [23] suggested that although gene duplication does occur
it is often deleterious due to unbalanced gene dosage. It is
presumed that genes that vary in copy number would have
expression levels that would depend on the copy number of the
gene. The CNVs studied here belong to HapMap individuals and
most are not thought to be associated with major diseases but are
thought to be neutral mutations. However, it was still a surprise to
discover that the expression of the genes associated with these
CNVs was similar to that of the wild type copy number
irrespective of copy number and whether the gene was entirely
within the CNV as in type I or merely overlapped the CNV as in
type II and III. This suggests that some sort of dosage
compensation mechanism must be involved in the regulation of
these genes.
MiRNAs might be a likely dosage compensation mechanism for
type I genes as they are duplicated (or deleted) in their entirety
thus maintaining intact 39UTRs. However, this was not the case as
type I genes showed a significant paucity of genes regulated by
miRNAs and those genes that did have predicted miRNA targets
had significantly fewer targets than expected even allowing for the
short 39UTRs of these genes. The shorter 39UTRs and lack of
regulation by miRNAs of these type I genes is similar to what has
been found for housekeeping genes [24–26]. It is thought that
house keeping genes have evolved short UTRs to avoid
‘‘accidental’’ regulation by miRNAs as it is easier for a single
Table 3. DAVID Functional Annotation Clustering for CNV
Genes.
CNV gene type DAVID Functional Clusters Enrichment Score
I Immunoglobulin 31.7
I MHC 19.84
I Olfactory Receptor 4.62
I Glutathionine S Transferase (GST) 2.71
I hormone 2.53
I Keratin 2.13
I Chromatin Associated 1.31
II APOBEC (mRNA editing) 1.66
II Cell adhesion 1.53
II Plexin fold (extracellular) 1.5
II Keratin 1.47
III plasma membrane 4.44
III cell-cell signaling 3.9
III synapse 3.75
III ion binding 3.75
III SH3 domain (extracellular) 3.66
III Fibronectin (extracellular) 3.39
III EGF (extracellular) 3.24
III Nucleotide binding 3.09
III Sushi (extracellular) 3.09
III Cell adhesion 3.01
doi:10.1371/journal.pone.0014814.t003
CNV Gene Classification
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create a new transcription factor biding site [27]. However, type I
genes showed no significant enrichment for housekeeping genes
(data not shown). For example, the MHCII genes which are
enriched in type I genes, have evolved rapid mutation rates to keep
up with the ‘‘arms race’’ in their fight against pathogens. MHCII
genes lack miRNA targets and are all regulated by the Class II
TransActivator (CIITA) which has a low affinity binding site that
is difficult to disrupt by point mutation [28]. This hints that rapidly
evolving type I genes are less likely to be regulated by miRNAs and
have also evolved short 39UTRs for the same reasons as house
keeping genes despite the fact that housekeeping genes have low
mutation rates.
The fact that genes such as the MHC genes that are under
balancing selection in type I genes may be due to their
requirement for ongoing variation as copy number variation is
another method of increasing the potential for variation amongst
individuals.
The type III genes are under very different evolutionary
pressures than type I genes as they have evolved long UTRs and
are significantly enriched for genes that are regulated by miRNAs.
Their lower mutation rates mean that miRNA targets are less
likely to be disrupted by point mutation. There is the possibility
that the CNV itself might disrupt the UTR but most CNV
breakpoints in type III genes are within the introns (nearly 90%)
and are often associated with repetitive elements such as Alu [1],
so the CNV is unlikely to disrupt the 39UTR and it’s miRNA
targets (only nine of the 1172 type III genes had their 39UTRs
disrupted by the CNV). Also, CNVs that completely overlap the
39UTR will be classified as type II genes.
The type III genes are significantly enriched for genes that are
normally monoallelically expressed. Initially this result was rather
surprising but recent work by Necsulea et al. [29] linking
monoallelic expression with recombinant hotspots may help to
explain this significant enrichment. Necsulea et al. [29] hypothe-
sised that the differential methylation status of the silenced and
active alleles of the monoallelically expressed genes may somehow
be responsible for the increased recombinant hotspots in these
genes. This begs the question whether the same mechanisms may
be responsible for these recombinant hotspots as well as the CNV
breakpoints?
The gene functional annotation clustering highlighted that
many type III genes produce proteins that contain extracellular
domains which agrees with Gimelbrant et al. [14]who found many
monoallelically expressed genes were involved in cell to cell
signalling. These domains are known to have evolved through the
evolutionary process of exon shuffling [30] where whole exons and
domains are duplicated or deleted within a gene. It is interesting
that this mechanism is currently in action in the human genome.
Unlike type I genes, type III genes appear to be regulated by a
number of potential dosage compensation mechanisms despite
being present in just the wild type copy number. However, we
agree with one of our reviewers who suggested that the complex
nature of the different isoforms that may be produced might
require more complex methods to regulate their expression.
The type II genes appear to fall between type I and III genes
which makes them appear to be not significantly different to non
CNV genes. This may be due in part to the miscategorisation of
some type I or III genes as type II genes due to incorrect
annotation of the UTRs or of the CNV breakpoint. However, the
Figure 2. Frequency distribution graphs of expression ratios. Expression ratio distribution for the same individuals and the same expression
data as analysed by Schuster-Bo ¨ckler et al. [4]. Only type I genes based on the CNV coordinates from Conrad et. al. [1] were used.
doi:10.1371/journal.pone.0014814.g002
CNV Gene Classification
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become fusion genes for example in a-Thalassemia. Therefore,
more research is required to fully understand this class of genes.
Conclusion
Initially, this research set out to investigate how genes in copy
number variable regions maintained expression levels similar to
those of the wild type copy number. A new classification and
characterization of CNV genes was required so that only the
genes that fell entirely with in a CNV and that varied in copy
number, would be used in studying gene expression. The
characterisation was, originally based on the physical relationship
of the gene with the CNV, however, it soon became apparent
that this classification was biologically important. The genes in
the three categories differ in their regulation and mutation rates
as well as in the type of gene involved. Type I genes tend to be
involved in immune response or sensory receptors while type III
genes are involved in cell to cell signalling and type II genes are a
complex mix of all three types.
While we still do not understand the homeostatic mechanisms
involved in type I genes we do know that type III genes are more
likely to be regulated by miRNAs and be monoallelically
expressed. Type I genes appear to have evolved to avoid
regulation by miRNAs as a necessity given their fast mutation
rates and are also unlikely to be monoallelically expressed.
Further research is required as we still do not understand the
mechanisms that underlie the homeostatic regulation of these
CNV genes. Hopefully, new datasets such as histone and DNA
modification scans will help shed light on why gene expression
levels do not appear to be correlated with gene copy number.
Disruption of these homeostatic mechanisms whether by CNVs or
other mechanisms can often lead to disease. Therefore this is an
important area for further research.
Methods
All statistics were performed in R (http://www.R-project.org).
Data manipulation was performed in Perl. Whilst, access to
Ensembl version 53 was via the Perl API. [31] or Biomart [32].
The dN and dS values for the human/chimp one to one
orthologues were obtained from Ensembl Compara as these have
a high confidence of being true orthologues and compared with
the Kolmogorov-Smirnov (KS) test. Note that the KS test is
thought to be better for larger data sets such as those used here.
The ensembl gene ids for the three types of genes are available
as supplemental information (Data S1).
Figure 3. Expression ratio for each type I gene. Expression ratios (normalised expression) for each duplicated and deleted type I genes. Note
that although there are more duplicated genes with higher expression ratios the vast majority of both duplicated and deleted genes have an
expression ratio very close to one rather than the 0.5 (1 copy) or .1.5 (.3 copies) expected. These distributions are similar to those of Supplemental
figure S1.
doi:10.1371/journal.pone.0014814.g003
Table 4. Observed and expected numbers of imprinted and
monoallelically expressed genes for the three types of CNV
gene.
Imprinted genes (expected) Monoallelic genes (expected)
Type I 2 (3.368) 1 (11.053) ***
Type II 3 (3.032) 9 (9.947)
Type III 15 (9.399) 129 (30.842)***
Significance levels indicated by *** = p,0.005.
doi:10.1371/journal.pone.0014814.t004
CNV Gene Classification
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The co-ordinates for the CNVs were obtained from The
Copy Number Variation (CNV) Project (http://www.sanger.
ac.uk/humgen/cnv/data/), for the Redon et al. [33] and http://
www.sanger.ac.uk/humgen/cnv/42mio/download_genotype_data.
html for the Conrad et al. [1] data. The individuals used in this
analysis were the unrelated individuals from Yoruba in Ibadan,
Nigeria (YRI); Japanese in Tokyo, Japan (JPT); Han Chinese in
Beijing, China (CHB); CEPH (Utah residents with ancestry from
northern and western Europe) (CEU). It should be noted that there
was no phenotypic information collected with sample sets therefore
we cannotdescribethese celllinesasnormal controls[34]. However,
the presence of the same CNVs in different populations suggests that
many of these CNVs are ‘‘normal’’ neutrally evolving genomic
rearrangements.
CNV Genes
The CNV co-ordinates are for the ncbi36 assembly of the
human genome so the Ensembl API for ensembl version 53
(homo_sapiens_core_53_36o) [31] was used to map protein
coding genes that overlapped with the CNV co-ordinates. Genes
that were found to be entirely within the CNV breakpoints are
classified as type I genes whilst those that overlap a CNV are type
II. Some CNVs are complex with different individuals having
different co-ordinates and copy numbers for CNVs in the same
region of the genome. In these cases where the same gene may be
classified as type I in one individual and type II in another, the
gene was given the type I classification for the miRNA analysis but
was counted as both in the expression analysis.
Note that only genes from the autosomal chromosomes are
used.
Expression Data
The expression data for the HapMap cell lines were obtained
from ftp://ftp.sanger.ac.uk/pub/genevar [3]. Both the raw and
the normalised (across all populations) data were downloaded. The
expression results were filtered by probability (.0.95) as well as the
variance of raw expression values. A value of .49 was used based
on the work of Schuster-Bo ¨ckler et al. [4], as it has been shown that
probes with very low variance usually have low expression and are
often at the limit of the sensitivity of the arrays [3,4].
Ensembl genes without probes were not included in this
analysis. Some probes represented more than one gene. in which
case one probe was randomly taken to represent the gene. The
expression ratio analysis was performed as described by Schuster-
Bo ¨ckler et al. [4]
miRNA Targets
The experimentally verified miRNA target genes were down-
loaded from TarBase version 5 [19] and mapped to Ensembl gene
identifiers.
The predicted miRNA target datasets came from miRGen
version 3 [20]. We used the union and intersect datasets of
miranda [20] http://www.microrna.org); PicTar miRNA target
prediction from 4 way conservation with Human, Mouse, rat, and
dog [22] http://pictar.mdc-berlin.de/) and TargetScanS (Tar-
getScanS release 3.1. [18] http://www.targetscan.org/).
A simple x
2 analyses was used to test whether more or less genes
than expected were predicted to be regulated by miRNAs. The
expected values were calculated as expected value = Row total *
Column total/Total for table.
The Kolmogorov-Smirnov test was used to compare the distribu-
tions for the numbers of predicted targets per gene for each gene type.
Imprinted and Monoallelic Genes
The imprinted gene list was taken from the Catalogue of parent of
Origin Effects database [13] and the monoallelically expressed genes
were taken fromthe workbyGimelbrant et al. [13].Againa x
2test was
to test whether these genes were enriched or not in the CNV genes.
Cluster Analysis
The gene functional clustering was performed using DAVID,
(The Database for Annotation, Visualization, and Integrated
Discovery [35] from National Institute of Allergy and Infectious
Diseases (NIAID), NIH, using lists of Ensembl identifiers.
Supporting Information
Figure S1 Expression ratios for type II (A) and III (B) genes.
Expression ratios (normalised expression) for each gene for
duplicated and deleted genes as for figure 3.
Found at: doi:10.1371/journal.pone.0014814.s001 (1.53 MB TIF)
Data S1 CNV genes. CNV genes used in this analysis.
Found at: doi:10.1371/journal.pone.0014814.s002 (0.18 MB
TXT)
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Table 5. Summary of results for the three types of CNV genes for miRNA target analysis.
Gene type
Number of
Genes
No of Genes with
miRNA targets
predicted for
Intersect Data
Set (Expected)
Mean no. of
Intersect miRNAs
predicted per gene
(median)
No of Genes with
MiRNA targets
predicted by Union
(Expected)
Mean no. of Union
miRNAs predicted
per gene (median)
Mean no. of Union
targets per gene
(median)
39UTR Length
(median)
I 420 ***15 (39.500) 4.467 (3.000) ***352 (392.100) ***18.370 (12.500) ***24.320 (13.500) ***914 (561)
II 378 30 (33.745) 2.80 (2.000) 360 (352.875) 25.350 (20.000) 35.540 (24.000) 1299.000 (923.500)
III 1172 ***151 (104.628) 4.179 (3.000) ***1133 (1094.102) ***27.940 (25.000) ***41.23 (31.00) ***1777 (1335)
Non CNV 17980 1585 (1605) 3.503 (2.000) 16779 (16784) 24.84 (20.000) 33.960 (25.00) 1230 (815)
Significance levels indicated by *** probability ,0.005.
doi:10.1371/journal.pone.0014814.t005
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